News

Recovery in 2021? These three factors could derail a vaccine-led rebound, Goldman Sachs warns

These risks could dent a consumer boom led by pent-up demand this year

The client note from Goldman Sachs chief economist Jan Hatzius identifies three main downside risks that could ruin the sunny projection for a recovery spurred by the vaccine schedule
The client note from Goldman Sachs chief economist Jan Hatzius identifies three main downside risks that could ruin the sunny projection for a recovery spurred by the vaccine schedule Photo: Getty Images

Goldman Sachs has identified three factors they worry could dent a Covid-19 vaccine-led economic recovery in 2021.

Analysts at the bank said they expected a reduction in virus risk, thanks to mass vaccination coupled with fiscal support for consumer spending, which they expect will lead to a “mid-year consumption boom and very strong growth for 2021”.

WSJ Logo
Pro Bono or Pro Nono? Law Firms Split on Fulfilling Deals With TrumpExternal link

Pro Bono or Pro Nono? Law Firms Split on Fulfilling Deals With Trump